Revascularization Strategies in Multivessel Coronary Disease: Contemporary Evidence, Clinical Outcomes, and Future Perspectives

doi:N/A

Bangaldesh Journal of Cardivascular Medicine

2025, Volume 3, Issue 1 : 1-4

Research Article

Revascularization Strategies in Multivessel Coronary Disease: Contemporary Evidence, Clinical Outcomes, and Future Perspectives

Jonathan M. Carter

Sophia L. Richardson

David K. Williams

Emily R. Thompson

⁴

Ahmed N. Hassan

⁵

Department of Interventional Cardiology, Heart and Vascular Institute, Boston, USA

Division of Cardiovascular Medicine, University Hospital London, United Kingdom

Department of Cardiovascular Research, Sydney Cardiac Centre, Australia

⁴

Department of Cardiothoracic Surgery, European Heart Institute, Berlin, Germany

⁵

Department of Cardiology, International Cardiovascular Research Foundation, Dubai, UAE

Abstract

Background

Multivessel coronary artery disease (MVD) affects approximately 40–60% of patients undergoing coronary angiography and remains a major contributor to cardiovascular morbidity and mortality worldwide. The optimal revascularization strategy—whether percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), or hybrid coronary revascularization (HCR)—continues to evolve with advancements in technology, imaging, and evidence-based practice.

Objective

To evaluate contemporary revascularization strategies in multivessel coronary disease, comparing clinical outcomes, procedural characteristics, and long-term prognosis associated with PCI, CABG, and hybrid approaches.

Methods

A multicenter comparative study involving 720 patients with angiographically confirmed multivessel coronary artery disease was conducted. Patients underwent PCI (n=320), CABG (n=280), or HCR (n=120). Procedural outcomes, in-hospital events, and 24-month major adverse cardiovascular and cerebrovascular events (MACCE) were analyzed.

Results

CABG demonstrated the lowest rate of repeat revascularization (6.4%), while PCI showed shorter hospital stays and lower procedural morbidity. Hybrid revascularization provided favorable outcomes with reduced invasiveness and comparable survival. Twenty-four-month MACCE rates were 18.1% for PCI, 12.5% for CABG, and 13.3% for HCR.

Conclusion

CABG remains the preferred strategy for complex multivessel disease, particularly among diabetic patients and those with high anatomical complexity. PCI offers excellent outcomes in selected patients with less complex disease. Hybrid revascularization represents a promising alternative combining the benefits of surgical durability and minimally invasive intervention.

Keywords

Multivessel Coronary Disease

PCI

CABG

Hybrid Revascularization

Coronary Artery Disease

SYNTAX Score

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

Bangladesh J. Cardiovasc. Med. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.

Recommended Articles

Bleeding Risk Assessment in Interventional Cardiology: Contemporary Predictors, Risk Scores, and Prevention Strategies

Alexander M. Reed,

Sophia L. Bennett,

Daniel K. Morgan,

Emily R. Carter,

Ahmed N. Rahman

1-8

Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Balancing Ischemic Protection and Bleeding Risk in Contemporary Percutaneous Coronary Intervention

Michael R. Anderson,

Sarah T. Bennett,

Ahmed K. Rahman,

Priya Sharma,

David L. Cooper

1-6

Contemporary Management of Coronary Artery Perforation During Percutaneous Coronary Intervention: Incidence, Predictors, Treatment Strategies, and Clinical Outcomes

Mohammad Arif Hossain,

Sarah Ahmed,

Rajib Hasan,

Farhana Rahman,

Kamrul Islam

1-6

Outcomes of Percutaneous Closure of Ventricular Septal Defects

Alexander R. Thompson,

Priya Menon,

Samuel K. Ibrahim,

Elena V. Petrova

1-5